{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:01:39Z","timestamp":1770919299718,"version":"3.50.1"},"reference-count":27,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ThoracResPract"],"DOI":"10.4274\/thoracrespract.2025.2025-1-2","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T01:35:06Z","timestamp":1748914506000},"source":"Crossref","is-referenced-by-count":1,"title":["An Important Question: Can Serum Chitotriosidase Enzyme Predict the Activity and Clinical Course of Sarcoidosis Disease?"],"prefix":"10.4274","author":[{"given":"Ece","family":"\u015eahino\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha\u015fim","family":"Boyac\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hale Maral","family":"K\u0131r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Hamdi","family":"Ilgazl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130lknur","family":"Ba\u015fyi\u011fit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Argun Bar\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"ref0","unstructured":"1. Hunninghake GW, Costabel U, Ando M, et al. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(2):149-173. [Crossref]"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J. 2016;48(6):1690-1699. [Crossref]","DOI":"10.1183\/13993003.00477-2016"},{"key":"ref2","unstructured":"3. Muthuswamy PP, Lopez-Majano V, Ranginwala M, Trainor WD. Serum angiotensin-converting enzyme (SACE) activity as an indicator of total body granuloma load and prognosis in sarcoidosis. Sarcoidosis. 1987;4(2):142-148. [Crossref]"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Lynch JP, Ma YL, Koss MN, White ES. Pulmonary sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):53-74. [Crossref]","DOI":"10.1055\/s-2007-970333"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Gungor S, Ozseker F, Yalcinsoy M, et al. Conventional markers in determination of activity of sarcoidosis. Int Immunopharmacol. 2015;25(1):174-179. [Crossref]","DOI":"10.1016\/j.intimp.2015.01.015"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Turner-Warwick M, McAllister W, Lawrence R, Britten A, Haslam PL. Corticosteroid treatment in pulmonary sarcoidosis: do serial lavage lymphocyte counts, serum angiotensin converting enzyme measurements, and gallium-67 scans help management? Thorax. 1986;41(12):903-913. [Crossref]","DOI":"10.1136\/thx.41.12.903"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Bargagli E, Rottoli P. Serum chitotriosidase activity in sarcoidosis patients. Rheumatol Int. 2007;27(12):1187. [Crossref]","DOI":"10.1007\/s00296-007-0417-3"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Funkhouser JD, Aronson NN Jr. Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol Biol. 2007;7:96. [Crossref]","DOI":"10.1186\/1471-2148-7-96"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Cho SJ, Weiden MD, Lee CG. Chitotriosidase in the pathogenesis of inflammation, interstitial lung diseases and COPD. Allergy Asthma Immunol Res. 2015;7(1):14-21. [Crossref]","DOI":"10.4168\/aair.2015.7.1.14"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Grosso S, Margollicci MA, Bargagli E, et al. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest. 2004;64(1):57-62. [Crossref]","DOI":"10.1080\/00365510410004092"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Bargagli E, Margollicci M, Luddi A, et al. Chitotriosidase activity in patients with interstitial lung diseases. Respir Med. 2007;101(10):2176-2181. [Crossref]","DOI":"10.1016\/j.rmed.2007.05.008"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Bargagli E, Maggiorelli C, Rottoli P. Human chitotriosidase: a potential new marker of sarcoidosis severity. Respiration. 2008;76(2):234-238. [Crossref]","DOI":"10.1159\/000134009"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Brunner J, Scholl-B\u00fcrgi S, Prelog M, Zimmerhackl LB. Zimmerhackl, chitotriosidase as a marker of disease activity in sarcoidosis. Rheumatol Int. 2007;27(12):1171-1172. [Crossref]","DOI":"10.1007\/s00296-007-0363-0"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Bargagli E, Bennett D, Maggiorelli C, et al. Human chitotriosidase: a sensitive biomarker of sarcoidosis. J Clin Immunol. 2013;33(1):264-270. [Crossref]","DOI":"10.1007\/s10875-012-9754-4"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Popevi\u0107 S, \u0160umarac Z, Jovanovi\u0107 D, et al. Verifying sarcoidosis activity: chitotriosidase versus ACE in sarcoidosis - a case-control study. J Med Biochem. 2016;35(4):390-400. [Crossref]","DOI":"10.1515\/jomb-2016-0017"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Lopes MC, Amadeu TP, Ribeiro-Alves M, et al. Identification of active sarcoidosis using chitotriosidase and angiotensin-converting enzyme. Lung. 2019;197(3):295-302. [Crossref]","DOI":"10.1007\/s00408-019-00219-2"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Harlander M, Salobir B, Zupan\u010di\u010d M, Dolen\u0161ek M, Bav\u010dar Vodovnik T, Ter\u010delj M. Serial chitotriosidase measurements in sarcoidosis--two to five year follow-up study. Respir Med. 2014;108(5):775-782. [Crossref]","DOI":"10.1016\/j.rmed.2014.02.002"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Boot RG, Renkema GH, Verhoek M, et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998;273(40):25680-25685. [Crossref]","DOI":"10.1074\/jbc.273.40.25680"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Lee P, Waalen J, Crain K, Smargon A, Beutler E. Human chitotriosidase polymorphisms G354R and A442V associated with reduced enzyme activity. Blood Cells Mol Dis. 2007;39(3):353-360. [Crossref]","DOI":"10.1016\/j.bcmd.2007.06.013"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Bergantini L, Bianchi F, Cameli P, et al. Prognostic biomarkers of sarcoidosis: a comparative study of serum chitotriosidase, ACE, lysozyme, and KL-6. Dis Markers. 2019;2019:8565423. [Crossref]","DOI":"10.1155\/2019\/8565423"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Bennett D, Cameli P, Lanzarone N, et al. Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis. Respir Res. 2020;21(1):6. [Crossref]","DOI":"10.1186\/s12931-019-1263-z"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Boot RG, Hollak CE, Verhoek M, Alberts C, Jonkers RE, Aerts JM. Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis. Clin Chim Acta. 2010; 411(1-2):31-36. [Crossref]","DOI":"10.1016\/j.cca.2009.09.034"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Tercelj M, Salobir B, Simcic S, Wraber B, Zupancic M, Rylander R. Chitotriosidase activity in sarcoidosis and some other pulmonary diseases. Scand J Clin Lab Invest. 2009;69(5):575-578. [Crossref]","DOI":"10.1080\/00365510902829362"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Nakamura Y, Takeda T, Ishii M, et al. Elevation of serum angiotensin-converting enzyme activity in patients with hyperthyroidism. J Clin Endocrinol Metab. 1982;55(5):931-934. [Crossref]","DOI":"10.1210\/jcem-55-5-931"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Zorn SK, Stevens CA, Schachter EN, Gee JB. The angiotensin converting enzyme in pulmonary sarcoidosis and the relative diagnostic value of serum lysozyme. Lung. 1980;157(2):87-94. [Crossref]","DOI":"10.1007\/BF02713601"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Kruit A, Grutters JC, Gerritsen WB, et al. ACE I\/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med. 2007;101(3):510-515. [Crossref]","DOI":"10.1016\/j.rmed.2006.06.025"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Rust M, Bergmann L, K\u00fchn T, et al. Prognostic value of chest radiograph, serum-angiotensin-converting enzyme and T helper cell count in blood and in bronchoalveolar lavage of patients with pulmonary sarcoidosis. Respiration. 1985;48(3):231-236. [Crossref]","DOI":"10.1159\/000194834"}],"container-title":["Thoracic Research and Practice"],"original-title":[],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T11:29:17Z","timestamp":1755689357000},"score":1,"resource":{"primary":{"URL":"https:\/\/thoracrespract.org\/articles\/an-important-question-can-serum-chitotriosidase-enzyme-predict-the-activity-and-clinical-course-of-sarcoidosis-disease\/doi\/ThoracResPract.2025.2025-1-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":27,"URL":"https:\/\/doi.org\/10.4274\/thoracrespract.2025.2025-1-2","relation":{},"ISSN":["2979-9139"],"issn-type":[{"value":"2979-9139","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]}}}